Gsa Capital Partners LLP Rockwell Medical, Inc. Call Options Transaction History
Gsa Capital Partners LLP
- $1.2 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RMTI
# of Institutions
45Shares Held
5.56MCall Options Held
154KPut Options Held
10.4K-
Vanguard Group Inc Valley Forge, PA1.35MShares$1.26 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny562KShares$522,8500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA323KShares$300,5270.0% of portfolio
-
Black Rock Inc. New York, NY219KShares$203,4100.0% of portfolio
-
State Street Corp Boston, MA101KShares$93,8400.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $9.93M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...